|

albumin-bound paclitaxel+trastuzumab+pyrotinib Clinical Trials

1 actively recruiting trial

Also known as: Cohort8 (HER2-positive, albumin-bound paclitaxel + trastuzumab + pyrotinib)

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.